141 results
P
patients with stable chronic obstructive pulmonary disease (COPD), healthy controls
I/C
measuring FeNO levels, comparing FeNO levels between patients with stable COPD and healthy controls
O
elevated FeNO levels in patients with stable COPD, decreased FeNO levels in smokers
P
upwardly mobile, downwardly mobile, stable high SES, stable low SES
I/C
social mobility, stable high SES, stable low SES
O
mental health problems
P
patients with stable atherosclerosis, controls
I/C
sCD40L levels, territory (carotid, coronary, etc.)
O
dysregulation of sCD40L levels
P
patients with stable coronary artery disease (CAD)
I/C
coronary artery bypass grafting (CABG), medical therapy (MT)
O
all-cause mortality
P
older adults, type II odontoid fractures
I/C
surgical management, nonoperative management, fusion rates, stable and unstable nonunion, mortality, complications
O
higher fusion rates, higher stable nonunion rates, lower mortality rates, higher complication rates
P
stable coronary artery disease (CAD) patients
I/C
coronary bypass (CABG), stenting, optimal medical therapy (OMT), OMT, CABG, durable-polymer-CoCr-everolimus-eluting stent, bio-absorbable-polymer-CoCr-sirolimus eluting stent
O
all-cause mortality, myocardial infarction (MI)
P
patients with stable asthma
I/C
physical exercise-assisted routine therapy, drug therapy and/or physical exercise
O
pulmonary function
P
patients with chronic obstructive pulmonary disease (COPD) in stable phase
I/C
conventional therapy combined with moxibustion, conventional treatment
O
number of acute exacerbations
P
patients undergoing total gastrectomy for gastric cancer
I/C
J-pouch (JP) reconstruction, standard Roux-en-Y (RY) esophagojejunostomy
O
dumping syndrome, heartburn symptoms
P
patients with stable ischemic heart disease (SIHD)
I/C
revascularization plus optimal medical therapy (OMT), OMT alone
O
all-cause mortality, cardiac mortality, myocardial infarction (MI), unstable angina, freedom from angina, stroke